Erich Platzer - Chairman of the Board @ Vivoryon Therapeutics

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

91,637

Primary Job Title Chairman of the Board
Primary Organization
Vivoryon Therapeutics

Location Basel-Landschaft, Switzerland, Europe
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Erich Platzer is based out of Basel-Landschaft and is the Chairman of the Board of Vivoryon Therapeutics. Erich previously worked at Panavance Therapeutics as a Board Member. Erich Platzer attended the FAU Erlangen-Nürnberg.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Hylomorph	StartAngels Network	Yes	Series B - Hylomorph	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Erich Platzer

is the

Chairman of the Board

Vivoryon Therapeutics

. Additionally,

Erich Platzer

has had

past job as the

Healthcare Partner & Member of the Board of Directors

MTIP AG

Vivoryon Therapeutics Chairman of the Board2007

Organization Name	Title At Company	Start Date	End Date
MTIP AG	Healthcare Partner & Member of the Board of Directors	—	2024

Board and Advisor Roles

Number of Current Board & Advisor Roles

Erich Platzer

holds

board and advisor roles including

Board Member

NitiNotes

Member of The Supervisory Board

Coramaze Technologies

, and

Advisor

MTIP AG

NitiNotes Board MemberNov 2024
Coramaze Technologies Member of The Supervisory BoardNov 2024
MTIP AG Advisor2015
Viroblock Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Europe, Middle East, and Africa (EMEA) Health Care Companies (Top 10K)	952
Therapeutics Companies that Exited	12,572
TVM Capital Portfolio Companies	91,150
Therapeutics Companies (Top 10K)	3,015
Biotechnology Public Companies With More Than 100 Employees	5,879
Andera Partners Portfolio Companies	77,195
Health Care Public Companies	6,372
Europe Public Companies With More Than 10 Employees	4,372
Biotechnology Public Companies With More Than 10 Employees	5,048
Therapeutics Companies With More Than 50 Employees	13,520